Clinical Trials Logo

Total Fluid Volume Increased clinical trials

View clinical trials related to Total Fluid Volume Increased.

Filter by:
  • None
  • Page 1

NCT ID: NCT02361736 Recruiting - Clinical trials for Total Fluid Volume Increased

Evaluate the Nephrotoxicity by 6% Hydroxyethyl Starch 130/0.4 in Old Patients During Orthopaedic Surgery

Start date: March 2015
Phase: N/A
Study type: Interventional

Hydroxyethyl starch (HES) is commonly used as plasma expander during surgery but may be nephrotoxic as seen in studies in patients with sepsis. The investigators hypothesized that the possible nephrotoxicity of 6% HES 130/0.4 could be revealed by measurements of urinary and plasma neutrophil gelatinase-associated lipocalin and interleukin-18 (IL-18) in old patients with normal renal function during orthopaedic surgery.

NCT ID: NCT01369524 Completed - Clinical trials for Total Fluid Volume Increased

Effect of Fluid Resuscitation and Microcirculation

Start date: January 2011
Phase: N/A
Study type: Observational

Although the investigators take many measurements to monitor the fluid state of the patients, it is not known exactly whether the fluid has real effect on the organ perfusion. The main focus of fluid is to improve the organ perfusion. Recent research has focused on the investigation of sublingual microcirculatory alterations.